跳至主要内容
临床试验/JPRN-jRCT2031210422
JPRN-jRCT2031210422招募中未知

Survey of proper use and occurrence of hyperkalemia after administration of MINNEBRO tablets in patients with hypertension- EBM Provider Cohort Study

Matsuoka Yomei0 个研究点目标入组 15,000 人开始时间: 2021年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
15,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Prescription of MINNEBRO tablets has commenced during the enrollment period (May 13, 2019 to May 31, 2023).
  • The diagnosis of hypertension exists on the same month as the date of the first prescription of this drug during the enrollment period.
  • The date of the earliest medical record after the start date of the data period is 180 days or more prior to the date of the first prescription of this drug.

排除标准

  • 未提供

研究者

发起方
Matsuoka Yomei

相似试验

Survey of proper use and occurrence of hyperkalemia... | 临床试验